Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

BACKGROUND: Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) has an annual incidence rate of 104–183 per 100,000 person-years. After a VTE episode, the two-year recurrence rate is about 17%. Consequently, effective and safe anticoagulation is paramount....

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Alexander T., Ay, Cihan, Hainaut, Philippe, Décousus, Hervé, Hoffmann, Ulrich, Gaine, Sean, Coppens, Michiel, da Silva, Pedro Marques, Castro, David Jimenez, Amann-Vesti, Beatrice, Brüggenjürgen, Bernd, Levy, Pierre, Bastida, Julio Lopez, Vicaut, Eric, Laeis, Petra, Fronk, Eva-Maria, Zierhut, Wolfgang, Malzer, Thomas, Bramlage, Peter, Agnelli, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928573/
https://www.ncbi.nlm.nih.gov/pubmed/29719492
http://dx.doi.org/10.1186/s12959-018-0163-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928573/
https://www.ncbi.nlm.nih.gov/pubmed/29719492
http://dx.doi.org/10.1186/s12959-018-0163-7

Ejemplares similares